Government body · founded 1937
National Cancer Institute
Bethesda, United States · cancer.gov
Part of United States Department of Health and Human Services
- Citations, last 5 years
- 226.7k
- Works, last 5 years
- 19k
- h-index
- 1,606
- Scientists listed
- 496
- Grants since 2016
- 95
Grants received
2021–2024 · grant · BCRP
Improving the Therapeutic Index of ADCs Targeting Metastatic Breast Cancer
Brad St. Croix · National Cancer Institute · funded by Congressionally Directed Medical Research Programs
2021–2024 · fellowship · FI2
Polymicrobial interactions between commensal obligate anaerobic bacteria and cystic fibrosis pathogen P. aeruginosa
Britney Lashawn Hardy · National Cancer Institute · funded by National Institutes of Health
2021–2025 · grant · RCRP
Single-Cell CRISPRa Screen to Identify Transcription Factors That Mediate Neuroblastoma Phenotypic Switching and Chemotherapy Drug Resistance
Zhihui Liu · National Cancer Institute · funded by Congressionally Directed Medical Research Programs
2021–2024 · grant · BCRP
Improving the Therapeutic Index of ADCs Targeting Metastatic Breast Cancer
Martin Schnermann · National Cancer Institute · funded by Congressionally Directed Medical Research Programs
2021 · research · PCF Young Investigator Award
Identification and Mechanistic Analysis of RB1/TP53 Loss Dependent Transcription and Epigenetic Factors Encoding Lineage Plasticity and Growth
Sonam Raj · National Cancer Institute · funded by Prostate Cancer Foundation
2021 · career development · Career Development Award (Peer reviewed and Funded by NCI)
Next Generation Immunoepigenetics: Targeting SMYD3 in HPV-negative Head and Neck Cancer.
Vassiliki Saloura · National Cancer Institute · funded by Conquer Cancer Foundation
2021 · career development · Young Investigator Award (Peer Reviewed and Fundable)
Targeting ATR to overcome PARP inhibitor resistance
Nobuyuki Takahashi · National Cancer Institute · funded by Conquer Cancer Foundation
2020–2021 · award
Investigating molecular and cellular roles of metabolism in RNA epigenetics
Christina Fitzsimmons · National Cancer Institute · funded by American Cancer Society
2020–2024 · research · Global Health
National Cancer Institute - to evaluate the non-inferiority of 1-dose of Cervarix (HPV2) in girls vs. 3-doses of Gardasil (HPV4) in women
National Cancer Institute · funded by Bill and Melinda Gates Foundation
2020–2021 · grant · PRCRP
Combating Recalcitrant Cancer Types Through Rational Engineering of Antibody-Drug Conjugates
James Dunleavey · National Cancer Institute · funded by Congressionally Directed Medical Research Programs
2020–2024 · grant · NFRP
Targeting the Core Transcriptional Regulatory Circuitry in Treating MPNSTs
Xiyuan Zhang · National Cancer Institute · funded by Congressionally Directed Medical Research Programs
2020–2022 · grant · PRCRP
New Antibody-Cytokine Fusion Proteins for the Therapy of Neuroblastoma
Hong Ha Rosa Nguyen · National Cancer Institute · funded by Congressionally Directed Medical Research Programs
2020–2023 · fellowship · FI2
Polymicrobial interactions between co-infecting cystic fibrosis pathogens
Tiffany Zarrella · National Cancer Institute · funded by National Institutes of Health
2020 · career development · Young Investigator Award (Peer Reviewed and Funded by NCI)
Evaluating the Immune Landscape and the Potential Role of ASPSCR1-TFE3 Fusions in Eliciting Response to Atezolizumab in Advanced Alveolar Soft Part Sarcoma
Abdul Rafeh Naqash · National Cancer Institute · funded by Conquer Cancer Foundation
2020 · training · International Development and Education Award
Conquer Cancer International Development and Education Award 2020: Muhammad Rafiqul Islam
Muhammad Rafiqul Islam · National Cancer Institute · funded by Conquer Cancer Foundation
2019–2025 · grant · PCRP
Development of Molecular Chaperone Inhibitors for (Re)Sensitization of CRPC to Enzalutamide and Abiraterone and to Synergize with Metabolic Inhibitors
William Linehan · National Cancer Institute · funded by Congressionally Directed Medical Research Programs
2019–2021 · grant · PCRP
Predicting Response to Intense Neoadjuvant Androgen Deprivation Therapy Through Spatial Genomics and Imaging Heterogeneity
Scott Wilkinson · National Cancer Institute · funded by Congressionally Directed Medical Research Programs
2019–2023 · grant · PCRP
Dynamics of Epigenetic Mechanisms in the Akt Signaling Pathway and Its Influences on Drug Response in Advanced Prostate Cancer
Remi Adelaiye-Ogala · National Cancer Institute · funded by Congressionally Directed Medical Research Programs
2019–2023 · grant · BCRP
RNA Methylation as a Modulator of Cancer Genome Instability
Pedro Batista · National Cancer Institute · funded by Congressionally Directed Medical Research Programs
2019–2022 · grant · PRCRP
An Investigation of Serum Levels of Per- and Polyfluoroalkyl Substances and Testicular Cancer Risk Within the Department of Defense Serum Repository
Mark Purdue · National Cancer Institute · funded by Congressionally Directed Medical Research Programs
2019–2023 · grant · BCRP
RNA Methylation as a Modulator of Cancer Genome Instability
Andre Nussenzweig · National Cancer Institute · funded by Congressionally Directed Medical Research Programs
2019 · career development · Young Investigator Award (Peer Reviewed and Funded by NCI)
A Phase I study evaluating the safety and tolerability of SLAMF7-targeting CAR T cells incorporating a suicide gene to treat relapsed multiple myeloma
Lekha Mikkilineni · National Cancer Institute · funded by Conquer Cancer Foundation
2019 · career development · Young Investigator Award (Peer Reviewed and Funded by NCI)
Investigating microbiota-immune interaction in Non-Small Cell Lung Cancer
Chen Zhao · National Cancer Institute · funded by Conquer Cancer Foundation
2019 · career development · Young Investigator Award (Peer Reviewed and Funded by NCI)
Overcoming Mutational Tumor Heterogeneity to Improve the Efficacy of Adoptive Cell Therapy for Patients with Metastatic Epithelial Cancers
Vid Leko · National Cancer Institute · funded by Conquer Cancer Foundation
2018–2021 · fellowship · FI2
What is the basis for telomere/centromere interchangeability in controlling nuclear envelope breakdown?
Adenrele Gleason · National Cancer Institute · funded by National Institutes of Health
2018–2026 · grant · BCRP
Leptomeningeal Metastases of Breast Cancer: Toward New Therapies
Stanley Lipkowitz · National Cancer Institute · funded by Congressionally Directed Medical Research Programs
2018–2023 · grant · RTR
A Biocompatible Therapeutic Platform for Precise Regulation of Vascularized Composite Allotransplant Rejection via Enhanced Costimulation Blockage
Joel Schneider · National Cancer Institute · funded by Congressionally Directed Medical Research Programs
2018–2023 · grant · PCRP
A Precision Medicine Study of How Inflammation May Underlie the Excessive Burden of Prostate Cancer in Men of African Ancestry
Stefan Ambs · National Cancer Institute · funded by Congressionally Directed Medical Research Programs
2018–2020 · grant · KCRP
A Nested Case-Control Study of Serum Levels of Polyfluoroalkyl Chemicals (PFCs) and Kidney Cancer Among Participants in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
Jonathan Hofmann · National Cancer Institute · funded by Congressionally Directed Medical Research Programs
2018–2021 · fellowship · FI2
Functional roles of the phase separation of mitochondrial DNA in aging
Marina Feric · National Cancer Institute · funded by National Institutes of Health
2018–2023 · grant · DMRDP
Targeted Therapeutics for Orthopedic Regeneration
Luis Alvarez · National Cancer Institute · funded by Congressionally Directed Medical Research Programs
2018–2021 · award
Pilot Study of Factors Impacting Medication Adherence in Children, Adolescents, and Adults with Neurofibromatosis Type 1 (NF1) on Clinical Treatment Trials
Staci Peron · National Cancer Institute · funded by Neurofibromatosis Therapeutic Acceleration Program
2018–2023 · grant · PCRP
A Combination Study of Durvalumab plus Olaparib in an Unselected Population with Metastatic Castrate-Resistant Prostate Cancer (mCRPC)
Fatima Karzai · National Cancer Institute · funded by Congressionally Directed Medical Research Programs
2018–2021 · fellowship · CIHR Fellowship
Metabolic signatures of triple negative breast cancer sensitivity and resistance to cyclophosphamide and doxorubicin in patient derived tumor xenografts
Thomas Velenosi · National Cancer Institute · funded by Canadian Institutes of Health Research
2018–2023 · grant · PCRP
High-Throughput Screen of Advanced Prostate Cancer Organoids and PDX Preclinical Trials to Identify Single and Combination Therapies Correlated with Genotype
Kathleen Kelly · National Cancer Institute · funded by Congressionally Directed Medical Research Programs
2018 · career development · Young Investigator Award (Peer Reviewed and Funded by NCI)
Bromodomain Inhibition in Combination with Topoisomerase I Inhibition in Children and Young Adults with Relapsed/Refractory Solid Tumors
Andrea Gross · National Cancer Institute · funded by Conquer Cancer Foundation
2018 · career development · Career Development Award (Peer Reviewed and Funded by NCI)
Integration of drug-resistance mutations in risk prognostication and monitoring of treatment response in CLL
Ihnye Ahn · National Cancer Institute · funded by Conquer Cancer Foundation
2018 · career development · James B. Nachman Endowed ASCO Junior Faculty Award in Pediatric Oncology
Targeted resequencing of pediatric rhabdomyosarcoma: report from the Children’s Oncology Group, the Children’s Cancer and Leukaemia Group, The Institute of Cancer Research UK, and the National Cancer Institute.
John Shern · National Cancer Institute · funded by Conquer Cancer Foundation
2018 · career development · Career Development Award (Peer reviewed and Funded by NCI)
Temozolomide for Prevention of HER2+ Breast Cancer Brain Metastases
Alexandra Zimmer · National Cancer Institute · funded by Conquer Cancer Foundation
2017–2019 · grant · BCRP
Detection of Breast Cancer Progression through Steroid Receptor Crosstalk Associated with Chromatin Remodeling Events
Erin Swinstead · National Cancer Institute · funded by Congressionally Directed Medical Research Programs